King Michael 4
4 · SAB Biotherapeutics, Inc. · Filed Feb 23, 2024
Insider Transaction Report
Form 4
King Michael
CHIEF FINANCIAL OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2024-02-21+115,000→ 115,000 totalExercise: $5.17Exp: 2034-02-21→ Common Stock (115,000 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock pursuant to the Company's 2014 Equity Incentive Plan.
- [F2]The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.